Influenzinum Pellet
Product Images NDC 0220-2733

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Influenzinum (NDC 0220-2733). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Influenzinum 2022 2023 8x)

This is a description of a homeopathic medicine called "Influenzinum 8". It contains 0.443 mg of active ingredient per pellet and is used for treating symptoms of influenza. The product comes with warnings, including not to use during pregnancy or while breastfeeding and to keep it out of reach of children. The directions recommend taking the pellets at the onset of symptoms. The text also contains contact information for the manufacturer and a list of inactive ingredients.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.